• The company on Wednesday opened Lilly Lebanon Advanced Therapies; plans to open Lilly Lebanon API by 2027.
• Lilly said its evolving pipeline, as well as anticipated demand for its medicines, prompted this additional commitment.
• Lilly's capital commitments to expand manufacturing in its home state now total $21 billion since 2020.

Drugmaker Eli Lilly (LLY) said Wednesday it will invest an additional $4.5 billion in its home state of Indiana to open a new facility focused on genetic diseases and to ramp up production of its newest weight-loss therapy, among other things.

The company said anticipated demand for its medicines, as well as its evolving pipeline of therapies, were among the reasons for the additional investment, bringing its total investments in the U.S. state to $21 billion since 2020.

At the time of writing, LLY stock was up marginally.

The Additional LLY Investment

As part of the investment, the company opened Lilly Lebanon Advanced Therapies, a genetic medicine manufacturing facility to support clinical and commercial production of advanced therapies targeting genetic diseases.

The company has also planned to open the Lilly Lebanon API, an active pharmaceutical ingredient facility, where it will introduce new processes and technologies.

“When our Lebanon API site opens in 2027, it will be the largest API production site in U.S. history, a commitment we chose to build here, at home,” said CEO David Ricks.

The company’s investment even caught the attention of U.S. President Donald Trump, who shared the announcement on his social media platform, Truth Social.

The investment will also help speed up the production of Foundayo, its recently approved weight-loss pill.

What Retail Traders Think About LLY

On Stocktwits, retail sentiment for LLY remained ‘extremely bullish’ amid ‘high’ message volumes over the last 24 hours.

LLY stock is down nearly 8% so far this year and has risen about 28% over the past 12 months, underperforming the S&P 500.

For updates and corrections, email newsroom[at]stocktwits[dot]com.